In line with this observation, neither PARP1/2 KD in cancer cells nor PARP1/2 deletion in mice affected tumor growth in orthotopic mammary fat pad tumor implantation models (Supplementary Fig. 2j–m). This evidence concerns the gene PARP1 and neoplasm.